GAPDHP57

Across TCGA pan-cancer cohorts, GAPDHP57 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated GAPDHP57 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher GAPDHP57 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GAPDHP57 expression acts as an unfavorable survival marker.

MESO, KIRC, and UCS are the cancer types where GAPDHP57 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.121	0.589	<.001	108	view →
KIRC	DFS	Quartile	IV	0.188	0.590	.001	45	view →
UCS	DFS	Tertile	III,IV	0.146	0.439	.034	36	view →
PAAD	OS	Tertile	II,III,IV	0.141	0.626	<.001	27	view →
LIHC	DFS	Tertile	II,III,IV	0.236	0.436	.021	27	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	21	view →
THCA	DFS	Tertile	IV	0.027	0.937	<.001	18	view →
BRCA	DFS	Tertile	All	0.804	0.904	.022	12	view →
UCEC	DFS	Tertile	All	0.582	0.659	.037	12	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
HNSC	DFS	Tertile	III,IV	0.211	0.509	.042	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

GAPDHP57–MESO (OS)

Open the MESO breakdown →